opacify


Also found in: Dictionary, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • verb

Words related to opacify

make opaque

become opaque

Related Words

References in periodicals archive ?
Delayed contrast-enhanced CT obtained 60 sec after CTA allows even more time for contrast material circulation to opacify patent segments of the vessel lumen on either side of stenotic or occluded areas.
Oral contrast media predominantly opacify the small bowel and improve detection of intra-abdominal collections.
It reportedly will not discolor, opacify, or leach out of a wide range of thermoplastics.
1 DEFINITY([R]) is an ultrasound contrast agent for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.
If the stomach was not transected at the suture line, a leak may occur along the staple line and will opacify the excluded stomach (Figure 4).
Endoscopic retrograde cholangiopancreatography (ERCP) or percutaneous transhepatic cholangiography (PTC) can be diagnostic by showing that the dilated ducts opacify with contrast, but these are invasive procedures and are not without risk.
Its FDA approved product, Imagent, is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and thereby improve visualization of the main pumping chamber of the heart, and to improve delineation of the endocardial borders (walls) of the heart.
INDICATIONS: Optison is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders.
There were no associated inflammatory changes, and the lumen did not opacify with contrast (Figure 1).
The product has been approved for marketing in the US for use in patients with suboptimal echocardiograms to opacify the left ventricle and thereby improve visualization of the main pumping chamber of the heart, and to improve delineation of the endocardial borders of the heart.
These patents relate to Photogen's FDA-approved Imagent(R) (perflexane lipid microspheres) ultrasound contrast agent for use in patients with suboptimal echocardiograms to opacify the left ventricle, thereby improving visualization of the main pumping chamber of the heart, and to improve delineation of the endocardial borders of the heart.
Lantheus imaging products include the echocardiography contrast agent DEFINITY[R] Vial for (Perflutren Lipid Microsphere) Injectable Suspension, an ultrasound contrast agent for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border, ABLAVAR([R]) (gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease, TechneLite([R])(Technetium Tc99m Generator), Cardiolite([R]) (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), and Thallium 201 (Thallous Chloride Tl 201 Injection).
Lantheus imaging products include the echocardiography contrast agent DEFINITY([R]) Vial for (Perflutren Lipid Microsphere) Injectable Suspension, an ultrasound contrast agent for use in patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border, ABLAVAR([R]) (gadofosveset trisodium), a first-in-class magnetic resonance agent indicated for the evaluation of aortoiliac occlusive disease in adults with known or suspected peripheral vascular disease, TechneLite([R]) (Technetium Tc99m Generator), Cardiolite([R]) (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), and Thallium 201 (Thallous Chloride Tl 201 Injection).